查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606250

生物製药加工设备和耗材市场：2025-2030年按产品、应用和最终用户分類的全球预测

Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物製药加工设备及耗材市场规模为469.3亿美元，预计2024年将达512.5亿美元，复合年增长率为9.07%，2030年将达861亿美元，预计将达到美国8,000万美元。

生物製药加工设备和耗材市场包括生物製药生产所必需的各种工具、机械和材料，例如过滤器、层析法系统、反应器和一次性材料。这些成分对于将生物材料转化为治疗产品并确保纯度、功效和法规遵循至关重要。由于生物製药和生物相似药在慢性病治疗中的作用日益增强，需求不断增加，突显了对该设备的需求。应用范围从发酵和细胞培养等上游工程到精製和过滤等下游製程。主要最终用户包括製药公司、委外研发机构(CRO) 和学术机构。主要成长动力包括一次性系统的技术进步，这些技术进步可提高成本效率并最大限度地降低污染风险，以及增加对新生物药物研发的投资。为了确保产品品质和安全，对先进加工设备和消耗品的监管审查日益加强，也推动了市场的发展。在生物技术产业不断发展的新兴国家，市场扩张机会很大。然而，它们面临着设备成本高、监管要求严格以及生物製药製造流程复杂等限制的挑战。为了挖掘这个市场的潜力，企业应该专注于自动化和整合处理系统等创新，以简化操作并减少人为错误。此外，透过开发更永续、更环保的消耗品，我们可以满足对绿色製程不断增长的需求。此外，与研究机构的策略联盟可以加速产品开发和创新。总体而言，生物製药加工设备和耗材市场是一个充满活力的市场，其特点是技术快速发展和严格的品质标准，需要不断创新和适应才能实现持续的业务成功。

主要市场统计
基准年[2023] 469.3亿美元
预计年份 [2024] 512.5亿美元
预测年份 [2030] 861.8亿美元
复合年增长率（%） 9.07%

市场动态：快速发展的生物製药加工设备和消耗品市场的关键市场洞察

生物製药加工设备和耗材市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病流行和对标靶生物製药的需求
    • 政府对疫苗生产的措施和投资
    • 生物製药 CDMO 的增加和对高品质设备的需求
  • 市场限制因素
    • 生物製程设备及耗材的技术限制
  • 市场机会
    • 生物製药加工设备及耗材的进展
    • 生物製药製程的一次性系统简介
  • 市场挑战
    • 改变生物製药行业严格的安全要求

波特五力：驾驭生物製药加工设备与耗材市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更具弹性的市场地位。

PESTLE分析：了解外部对生物製药加工设备和耗材市场的影响

外部宏观环境因素在塑造生物製药加工设备和耗材市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物製药加工设备及耗材市场的竞争状况

对生物製药加工设备和消耗品市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生物製药加工设备及耗材市场供应商绩效评估

FPNV定位矩阵是评估生物製药加工设备和耗材市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘生物製药加工设备和耗材市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物製药加工设备和消耗品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的盛行率和对标靶生物药物的需求
      • 政府对疫苗生产的措施和投资
      • 生物製药 CDMO 的增加和对高品质设备的需求
    • 抑制因素
      • 生物製程设备及耗材的技术限制
    • 机会
      • 生物製药加工设备及耗材的进展
      • 生物製药加工中的一次性系统简介
    • 任务
      • 严格且不断变化的生物製药行业安全要求
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物製药加工设备及耗材市场：副产品

  • 生物製程容器
  • 反应器
    • 反应器
    • 可重复使用的反应器
  • 生物安全柜
  • 细胞培养产品
    • 细胞和细胞株
    • 细胞培养基
    • 试剂和补充品
    • 血清
  • 离心机
  • 层析法设备及耗材
  • 过滤系统
  • 培养箱
  • 混合系统
  • 消毒器

第七章生物製药加工设备及耗材市场：依应用分类

  • 单株抗体
  • 疫苗

第八章生物製药加工设备与耗材市场：依最终用户分类

  • 生物製药公司
  • 製药公司

第九章北美、南美洲生物製药加工设备及耗材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物製药加工设备及耗材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东、非洲生物製药加工设备及耗材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc.
  • CH Boehringer Sohn AG & Co. KG
  • Corning Incorporated
  • Danaher Corporation
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Liquidyne Process Technologies, Inc.
  • Lonza Group
  • Merck KGaA
  • Microfluidics International Corporation
  • Repligen Corporation
  • Sartorius AG
  • Solaris Biotechnology Srl
  • Solesis Medical Technologies, Inc.
  • Solvay SA
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-B16853779EA2

The Biopharmaceutical Processing Equipment & Consumables Market was valued at USD 46.93 billion in 2023, expected to reach USD 51.25 billion in 2024, and is projected to grow at a CAGR of 9.07%, to USD 86.18 billion by 2030.

The biopharmaceutical processing equipment and consumables market encompasses a broad range of tools, machines, and materials essential for the production of biopharmaceuticals, including filters, chromatography systems, bioreactors, and disposable materials. These components are crucial in converting biological materials into therapeutic products, ensuring purity, efficacy, and regulatory compliance. The necessity of this equipment is underscored by the growing demand for biologics and biosimilars due to their increasing role in treating chronic diseases. Application spans across upstream processes like fermentation and cell culture, as well as downstream procedures such as purification and filtration. The main end-users include pharmaceutical companies, contract research organizations (CROs), and academic institutes. Key growth drivers include technological advancements in single-use systems, which offer cost-effectiveness and minimized contamination risk, as well as rising investments in research and development of new biologic drugs. The market is also buoyed by the increasing regulatory scrutinization demanding sophisticated processing equipment and consumables to ensure product quality and safety. Opportunities for market expansion are significant in emerging economies with growing biotechnology sectors. However, limitations like the high cost of equipment, strict regulatory requirements, and the complexity of biopharmaceutical production processes pose challenges. To tap the potential of this market, companies should focus on innovations such as automated and integrated processing systems, which streamline operations and reduce human error. Additionally, the development of more sustainable and eco-friendly consumables could cater to the growing demand for greener processes. Further, strategic collaborations with research institutions could accelerate product development and innovation. Overall, the biopharmaceutical processing equipment and consumables market is dynamic, characterized by rapid technological advancements and strict quality standards, mandating continuous innovation and adaptation for sustained business success.

KEY MARKET STATISTICS
Base Year [2023] USD 46.93 billion
Estimated Year [2024] USD 51.25 billion
Forecast Year [2030] USD 86.18 billion
CAGR (%) 9.07%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Processing Equipment & Consumables Market

The Biopharmaceutical Processing Equipment & Consumables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for targeted biopharmaceuticals
    • Government initiatives and investments for vaccine production
    • Increasing number of biopharmaceutical CDMOs and need for quality equipment
  • Market Restraints
    • Technical limitations of bioprocessing equipment & consumables
  • Market Opportunities
    • Advancements in biopharmaceutical processing equipment & consumables
    • Introduction of single-use systems in biopharmaceutical processing
  • Market Challenges
    • Stringent and changing biopharmaceutical industry safety requirements

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Processing Equipment & Consumables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Processing Equipment & Consumables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Processing Equipment & Consumables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Processing Equipment & Consumables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Processing Equipment & Consumables Market

A detailed market share analysis in the Biopharmaceutical Processing Equipment & Consumables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Processing Equipment & Consumables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Processing Equipment & Consumables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Processing Equipment & Consumables Market

A strategic analysis of the Biopharmaceutical Processing Equipment & Consumables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Processing Equipment & Consumables Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., C.H. Boehringer Sohn AG & Co. KG, Corning Incorporated, Danaher Corporation, Eppendorf AG, Fujifilm Holdings Corporation, General Electric Company, Liquidyne Process Technologies, Inc., Lonza Group, Merck KGaA, Microfluidics International Corporation, Repligen Corporation, Sartorius AG, Solaris Biotechnology Srl, Solesis Medical Technologies, Inc., Solvay S.A., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Processing Equipment & Consumables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bioprocessing Containers, Bioreactors, Biosafety Cabinets, Cell Culture Products, Centrifuges, Chromatography Equipment & Consumables, Filtration Systems, Incubators, Mixing Systems, and Sterilizers. The Bioreactors is further studied across Disposable/Single-use Bioreactors and Reusable Bioreactors. The Cell Culture Products is further studied across Cell & Cell Lines, Cell Culture Media, Reagents & Supplements, and Serum.
  • Based on Application, market is studied across Monoclonal Antibody and Vaccine.
  • Based on End-User, market is studied across Biopharmaceutical Companies and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for targeted biopharmaceuticals
      • 5.1.1.2. Government initiatives and investments for vaccine production
      • 5.1.1.3. Increasing number of biopharmaceutical CDMOs and need for quality equipment
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of bioprocessing equipment & consumables
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biopharmaceutical processing equipment & consumables
      • 5.1.3.2. Introduction of single-use systems in biopharmaceutical processing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and changing biopharmaceutical industry safety requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Processing Equipment & Consumables Market, by Product

  • 6.1. Introduction
  • 6.2. Bioprocessing Containers
  • 6.3. Bioreactors
    • 6.3.1. Disposable/Single-use Bioreactors
    • 6.3.2. Reusable Bioreactors
  • 6.4. Biosafety Cabinets
  • 6.5. Cell Culture Products
    • 6.5.1. Cell & Cell Lines
    • 6.5.2. Cell Culture Media
    • 6.5.3. Reagents & Supplements
    • 6.5.4. Serum
  • 6.6. Centrifuges
  • 6.7. Chromatography Equipment & Consumables
  • 6.8. Filtration Systems
  • 6.9. Incubators
  • 6.10. Mixing Systems
  • 6.11. Sterilizers

7. Biopharmaceutical Processing Equipment & Consumables Market, by Application

  • 7.1. Introduction
  • 7.2. Monoclonal Antibody
  • 7.3. Vaccine

8. Biopharmaceutical Processing Equipment & Consumables Market, by End-User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Pharmaceutical Companies

9. Americas Biopharmaceutical Processing Equipment & Consumables Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Processing Equipment & Consumables Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Processing Equipment & Consumables Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Agilent Technologies, Inc
  • 3. Bio-Rad Laboratories, Inc.
  • 4. C.H. Boehringer Sohn AG & Co. KG
  • 5. Corning Incorporated
  • 6. Danaher Corporation
  • 7. Eppendorf AG
  • 8. Fujifilm Holdings Corporation
  • 9. General Electric Company
  • 10. Liquidyne Process Technologies, Inc.
  • 11. Lonza Group
  • 12. Merck KGaA
  • 13. Microfluidics International Corporation
  • 14. Repligen Corporation
  • 15. Sartorius AG
  • 16. Solaris Biotechnology Srl
  • 17. Solesis Medical Technologies, Inc.
  • 18. Solvay S.A.
  • 19. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOPROCESSING CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY DISPOSABLE/SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY REUSABLE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL & CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY REAGENTS & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY CELL CULTURE PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 242. BIOPHARMACEUTICAL PROCESSING EQUIPMENT & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2023